1. Agras WS, Dorian B, Kirkley BG, Arnow B, Bachman J. Imipramine in the treatment of bulimia: a double-blind controlled study. Int J Eat Disord 1987;6:29–38.

2. Agras WS, Rossiter EM, Arnow B, Schneider JA, Telch CF, Raeburn SD, Bruce B, Perl M, Koran LM. Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: a controlled comparison. Am J Psychiatry 1992;49:82–87.

3. Alger SA, Schwalberg MD, Bigaouette JM, Michalek AV, Howard LJ. Effect of a tricyclic antidepressant and opiate antagonist on binge-eating in normoweight bulimic and obese, binge-eating subjects. Am J Clin Nutr 1991;53:865–871.

4. Barlow J, Blouin J, Blouin A, Perez E. Treatment of bulimia with desipramine: a double-blind crossover study. Can J Psychiatry 1988;330:129–133.

5. Barry VC, Klawans HL. On the role of dopamine in the pathophysiology of anorexia nervosa. J Neural Transm 1976;38:107–122.

6. Biederman J, Herzog DB, Rivinus TM, Harper GP, Ferber RA, Rosenbaum JF, Harmatz JS, Tondorf R, Orsulak PJ, Schildkraut JJ. Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study. J Clin Psychopharmacol 1985;5:10–16.

7. Blouin AG, Blouin JH, Perez EL, Bushnik T, Zuro C, Mulder E. Treatment of bulimia with fenfluramine and desipramine. J Clin Psychopharmacol 1988;8:261–269.

8. Casper RC, Schlemmer RF, Javaid JI. A placebo-controlled crossover study of oral clonidine in acute anorexia nervosa. Psychiatry Res 1987;20:249–260.

9. Channon S, DeSilva WP. Psychological correlates of weight gain in patients with anorexia nervosa. J Psychiatr Res 1985;19:267–271.

10. Condon JT. Long-term neuroleptic therapy in chronic anorexia nervosa complicated by tardive dyskinesia. A case report. Acta Psychiatr Scand 1986;73:203–206.

11. Crisp AH. A treatment regime for anorexia nervosa. Br J Psychiatry 1966;112:505–512.

12. Crisp AH, Lacey JH, Crutchfield M. Clomipramine and `drive' in people with anorexia nervosa: an in-patient study. Br J Psychiatry 1987;150:355–358.

13. Dally P, Sargant W. A new treatment of anorexia nervosa. Br Med J 1960;1:1770–1773.

14. Dally P, Sargant W. Treatment and outcome of anorexia nervosa. Br Med J 1966;2:793–795.

15. de Zwaan M, Nutzinger DO, Schoenbeck G. Binge eating in overweight women. Compr Psychiatry 1992;33:256–261.

16. Eckert ED, Goldberg SC, Halmi KA, Casper RC, Davis JM. Depression in anorexia nervosa. Psychol Med 1981;11:1–8.

17. Fahy TA, Eisler I, Russell GFM. A placebo-controlled trial of d-fenfluramine in bulimia nervosa. Br J Psychiatry 1993;162:597–603.

18. Faltus F, Janeckova E. Levoprotiline-function regulator of food and satiety centres? Act Nerv Super (Praha) 1989;31:282–283.

19. Fava M, Herzog DB, Hamburg P, Riess H, Anfang S, Rosenbaum JF. Long-term use of fluoxetine in bulimia nervosa: a retrospective study. Ann Clin Psychiatry 1990;2:53–56.

20. Ferguson JM. Treatment of an anorexia nervosa patient with fluoxetine [Letter]. Am J Psychiatry 1987;144:1239–1239.

21. Fichter MM, Leibl K, Rief W, Brunner E, Schmidt-Auberger S, Engel RR. Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy. Pharmacopsychiatry 1991;24:1–7.

22. Fluoxetine Bulimia Nervosa Collaborative Study Group. Fluoxetine in the treatment of bulimia nervosa: a multicenter, placebocontrolled, double-blind trial. Arch Gen Psychiatry 1992;49:139–147.

23. Franklin JC, Schiele BC, Brozek J, Keys A. Observations on human behavior in experimental semistarvation and rehabilitation. J Clin Psychol 1948;4:28–45.

24. Freeman CPL, Davies F, Morris J, Cheshire K, Hampson M. A double-blind controlled trial of fluoxetine versus placebo for bulimia nervosa. Unpublished report, 1989.

25. Goldberg SC, Halmi KA, Eckert ED, Casper RC, Davis JM. Cyproheptadine in anorexia nervosa. Br J Psychiatry 1979;134:67–70.

26. Gross HA, Ebert MH, Faden VB, Goldberg SC, Nee Le, Kaye WH. A double-blind controlled trial of lithium carbonate in primary anorexia nervosa. J Clin Psychopharmacol 1981;1:376–381.

27. Gwirtsman HE, Guze BH, Yager J, Gainsley B. Fluoxetine treatment of anorexia nervosa: an open clinical trial. J Clin Psychiatry 1990;51:378–382.

28. Halmi KA, Eckert ED, LaDu TJ, Cohen J. Anorexia nervosa: treatment efficacy of cyproheptadine and amitriptyline. Arch Gen Psychiatry 1986;43:177–181.

29. Horne RL, Ferguson JM, Pope HG, Hudson JI, Lineberry CG, Ascher J, Cato A. Treatment of bulimia with bupropion: a multicenter controlled trial. J Clin Psychiatry 1988;49:262–266.

30. Hsu LKG. Eating disorders. New York: The Guilford Press, 1990.

31. Hsu LKG, Clement L, Santhouse R, Ju ESY. Treatment of bulimia nervosa with lithium carbonate. A controlled study. J Nerv Ment Dis 1991;179:351–355.

32. Hughes PL, Wells LA, Cunningham CJ, Ilstrup DM. Treating bulimia with desipramine: a double-blind, placebo-controlled study. Arch Gen Psychiatry 1986;43:182–186.

33. Kaye WH, Weltzin TE, Hsu LKG, Bulik CM. An open trial of fluoxetine in patients with anorexia nervosa. J Clin Psychiatry 1991;52:464–471.

34. Kennedy SH, Goldbloom DS, Ralevski E, Davis C, D'Souza J, Lofchy J. Is there a role for selective MAO-inhibitor therapy in bulimia nervosa? A placebo-controlled trial of brofaromine. J Clin Psychopharmacol 1993;13:415–422.

35. Kennedy SH, Piran N, Warsh JJ, Prendergast P, Mainprize E, Whynot C, Garfinkel PE. A trial of isocarboxazid in the treatment of bulimia nervosa. J Clin Psychopharmacol 1988;8:391–396.

36. Lacey JH, Crisp AH. Hunger, food intake and weight: the impact of clomipramine on a refeeding anorexia nervosa population. Postgrad Med J 1980;56(Suppl 1):79–85.

37. Leitenberg H, Rosen JC, Wolf J, Vara LS, Detzer MJ, Srebnik D. Comparison of cognitive-behavior therapy and desipramine in the treatment of bulimia nervosa. Behav Res Ther 1994;32:37–45.

38. Marcus MD, Wing RR, Ewing L, Kern E, Gooding W, McDermott M. A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge eaters and non-binge eaters. Am J Psychiatry 1990;147:876–881.

39. McCann UD, Agras WS. Successful treatment of nonpurging bulimia nervosa with desipramine: a double-blind, placebo-controlled study. Am J Psychiatry 1990;147:1509–1513.

40. Mitchell JE. Psychopharmacology of anorexia nervosa. In: Meltzer HY, ed. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987;1273–1276.

41. Mitchell JE, Christenson G, Jennings J, Huber M, Thomas B, Pomeroy C, Morley J. A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia. J Clin Psychopharmacol 1989;9:94–97.

42. Mitchell JE, Groat R. A placebo-controlled, double-blind trial of amitriptyline in bulimia. J Clin Psychopharmacol 1984;4:186–193.

43. Mitchell JE, Pyle RL, Eckert ED, Hatsukami D, Pomeroy C, Zimmerman R. A comparison study of antidepressants and structured group psychotherapy in the treatment of bulimia nervosa. Arch Gen Psychiatry 1990;47:149–157.

44. Pope HG, Hudson JI, Jonas JM, Yurgelun-Todd D. Antidepressant treatment of bulimia: a two-year follow-up study. J Clin Psychopharmacol 1985;5:320–327.

45. Pope HG Jr, Hudson JI, Jonas JM, Yurgelun-Todd D. Bulimia treated with imipramine: a placebo-controlled, double-blind study. Am J Psychiatry 1983;140:554–558.

46. Pope HG Jr, Keck PE Jr, McElroy SL, Hudson JI. A placebo-controlled study of trazodone in bulimia nervosa. J Clin Psychopharmacol 1989;9:254–259.

47. Potvin JH, Rampey AH, Roberts AH, Wheadon VL, Wilson MG. Fluoxetine vs. placebo in long-term treatment of bulimia nervosa: parallel/double-blind. Unpublished report, 1990.

48. Pyle RL, Mitchell JE, Eckert ED, Hatsukami D, Pomeroy C, Zimmerman R. Maintenance treatment and 6-month outcome for bulimic patients who respond to initial treatment. Am J Psychiatry 1990;147:7:871–875.

49. Russell GFM, Checkley SA, Feldman J, Eisler I. A controlled trial of d-fenfluramine in bulimia nervosa. Clin Neuropharmacol 1988;11(Suppl 1):S146–S159.

50. Sabine EJ, Yonace A, Farrington AJ, Barratt KH, Wakeling A. Bulimia nervosa: a placebo controlled double-blind therapeutic trial of mianserin. Br J Clin Pharmacol 1983;15:195S–202S.

51. Slaiman S. Restricted diets restrict antidepressant efficacy. Practitioner 1989;233:974–975.

52. Spitzer RL, Devlin MJ, Walsh BT, Hasin D, Wing RR, Marcus MD, Stunkard A, Wadden TA, Yanovski S, Agras WS, Mitchell J, Nonas C. Binge eating disorder: a multisite field trial for the diagnostic criteria. Int J Eat Disord 1992;11:191–203.

53. Spitzer RL, Yanovski S, Wadden T, Wing R, Marcus MD, Stunkard A, Devlin M, Mitchell J, Hasin D, Horne RL. Binge eating disorder: its further validation in a multisite study. Int J Eat Disord 1993;13:137–153.

54. Vandereycken W. Neuroleptics in the short-term treatment of anorexia nervosa: a double-blind placebo-controlled study with sulpiride. Br J Psychiatry 1984;144:288–292.

55. Vandereycken W, Pierloot R. Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa. Acta Psychiatr Scand 1982;66:445–450.

56. Vigersky RA, Loriaux DL. The effect of cyproheptadine in anorexia nervosa: a double-blind trial. In: Vigersky RA, ed. Anorexia nervosa. New York: Raven Press, 1977;349–356.

57. Walsh BT. Fluoxetine in the treatment of bulimia nervosa. J Psychosom Res 1991;35(Suppl 1):33–40.

58. Walsh BT, Gladis M, Roose SP, Stewart JW, Stetner F, Glassman AH. Phenelzine vs placebo in 50 patients with bulimia. Arch Gen Psychiatry 1988;45:471–475.

59. Walsh BT, Hadigan CM, Devlin MJ, Gladis M, Roose SP. Long-term outcome of antidepressant treatment for bulimia nervosa. Am J Psychiatry 1991;148:1206–1212.